Zoono CEO quits as financial woes mount

Zoono CEO quits as financial woes mount
Zoono's antiviral solution got some heavy use through the pandemic. (Image: Getty)
Denise McNabb
Zoono Group’s chief executive, Barry Woolcott, has resigned seven months into the job. He will leave the troubled New Zealand-based and Australian stock exchange (ASX) listed manufacturer of a proprietary long-life hand and surface sanitiser in January.His departure follows a review of the company’s overhead structure after Zoono reported an annual loss of $12.1 million for the June 2022 year and negative net operating cashflow of $2m in the first quarter to Sept 30. Administration and corporate costs of $1.5m exceeded cus...

More Markets

Thinking of investing? Skip 'most' of NZX
Opinion

Simon Robertson: Thinking of investing? Skip 'most' of NZX

If you want to grow your wealth, then buy the S&P 500. Period.

Fisher and Paykel Healthcare drives NZ stocks to weaker finish
Markets Market Close

Fisher and Paykel Healthcare drives NZ stocks to weaker finish

The S&P/NZX 50 Index closed down 31.63 points, or 0.23%, to 13,483.99.

Jamie Gray 05 Dec 2025
Fletcher Building extends bank covenant deal
Markets

Fletcher Building extends bank covenant deal

The company cannot pay a dividend until it meets its standard covenant levels.

Rebecca Howard 05 Dec 2025
The small standout performers on the NZX
Retail Small Cap Wrap

The small standout performers on the NZX

The small cap index has a blinder in 2025, some small cap awards, and more.